He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
The observations are of procedural in nature and will be responded to within the stipulated time
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Eugia Pharma Specialities restarts production at terminally sterilized product lines
IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
The product is expected to be launched in December 2023
The plant is yet to start commercial operations
Subscribe To Our Newsletter & Stay Updated
